Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Oncothyreon announces that Merck Serono is resuming the Stimuvax clinical program in lung cancer
Oncothyreon announces that Merck Serono is resuming the Stimuvax clinical program in lung cancer
Oncothyreon announces that Merck Serono is resuming the Stimuvax clinical program in lung cancer
Submitted by
admin
on June 17, 2010 - 9:19am
Source:
Yahoo/PR NewsWire
News Tags:
Oncothyreon
Merck Serono
Stimuvax
non-small cell lung cancer
Headline:
Oncothyreon announces that Merck Serono is resuming the Stimuvax clinical program in lung cancer
Do Not Allow Advertisers to Use My Personal information
